74. New MS Therapies: ATA-188 and BTK inhibitors

Dr. Brandon Beaber is a board-certified neurologist with subspecialty training in multiple sclerosis and other immunological diseases of the nervous system and spasticity.   He is also the author of "resilience in the face of multiple sclerosis" (free to anyone who wants it;  just ask him on twitter)!  Medical school: Drexel University college of medicine. Residency:  Los Angeles Medical Center. Fellowship: University of Southern California.     In todays episode, we talk about two new ground breaking therapies for people with progressive MS:  ATA-188 & BTK inhibitors. They’re both still in clinical trial, but they’re looking promising with ATA-188 actually showing improvement in those with progressive MS! Let’s dive in!   Twitter: https://twitter.com/messages/media/1523785137397280775 Youtube: https://www.youtube.com/c/DrBrandonBeaber   Find a clinical trial near you: clinicaltrials.gov Additional Resources: https://www.doctorgretchenhawley.com/insider Reach out to Me: [email protected]  Website: www.MSingLink.com Social:  ★ Facebook: https://www.facebook.com/groups/mswellness ★ Instagram: https://www.instagram.com/doctor.gretchen ★ YouTube: https://www.youtube.com/c/doctorgretchenhawley?sub_confirmation=1   → Game Changers Course: https://www.doctorgretchenhawley.com/GameChangersCourse → Total Core Program: https://www.doctorgretchenhawley.com/TotalCoreProgram → The MSing Link: https://www.doctorgretchenhawley.com/TheMSingLink